ArticlePharmacology research & perspectives2015

In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib.

Michael G Rolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.